Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review
- 1 June 2015
- journal article
- review article
- Published by Elsevier BV in Clinical Nutrition
- Vol. 34 (3), 359-366
- https://doi.org/10.1016/j.clnu.2014.11.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Dietaryω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of CancerBioMed Research International, 2013
- Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trialBMC Cancer, 2012
- Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCTEuropean Journal of Clinical Nutrition, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapyCancer, 2011
- Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancerCancer, 2011
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Cancer-related inflammationNature, 2008
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996